Core Scientific, Inc./tx
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 09/30/24 | FY 06/30/24 | FY 12/31/23 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.3 | $0.5 | — | — | $0.5 |
| Operating income | -$0.2 | -$0.1 | — | — | $<0.1 |
| Net income | -$0.3 | -$1.4 | — | — | -$0.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$0.5 | -$0.1 | — | — | $<0.1 |
| Share repurchases | — | $0.0 | — | — | $0.0 |
Shares outstanding 321.3M · Free float 61.0%
Annual filing data through FY ended December 31, 2025; float as of September 13, 2026.